Here are relevant reports on : surgical-tables-market
-
Hybrid Operating Room Market by Component (Surgical Booms, Surgical Lights, Operation Tables, MRI, CT, Angiography, AV Tools), Application (Cardiovascular, Neurovascular, Thoracic, Orthopedic), End User, and Region - Global Forecast to 2022
The global hybrid operating room market is expected to reach USD 1,174.9 Million by 2022 from USD 652.0 Million in 2017; growing at a CAGR of 12.5% during the forecast period. As of 2016, the major product manufacturers operating in the global hybrid operating room market included Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), among others.
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Operating Room Equipment Market by Equipment (Anesthesia Machines, Operating Tables), by Supplies (Surgical Instruments, Disposable Materials), & by End-User (Hospitals, Outpatient Facilities) - Global Forecast to 2020
The global operating room equipment market size is projected to grow at a CAGR of 3.7%. The growth of this market can be attributed to the growing investments, funds, and grants by government bodies worldwide, rising number of hospitals, increasing patient preference for minimally invasive surgeries, growing number of regulatory approvals for operating room equipment, and growing number of geriatric population coupled with the increasing number of surgeries globally.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Patient Positioning Systems Market Size by Product (Tables (Surgical Table, Imaging Table, Examination Table), Accessories, Application (Surgery, Diagnosis, Cancer Treatment), End User (Hospitals, ASCs, Diagnostic Labs)) & Region - Global Forecast to 2027
The global patient positioning systems market growth is primed to transition from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, showcasing a strong CAGR of 4.0%. Growth of the market is attributed to the increasing preference for minimally invasive surgeries and rising funding for new healthcare facility establishment.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Medical Furniture Market By Product [Medical Beds (Electric, Manual), Chairs (Gynecology, Bariatric), Tables, Cabinets, Trolleys], By Application [Long-term, Patient Care & Accommodation], End User [Hospitals, ASCs], By Region - Global Forecast to 2031
The Medical Furniture market, valued at US$13.43 billion in 2025, stood at US$14.02 billion in 2026 and is projected to advance at a resilient CAGR of 5.4% from 2026 to 2031, culminating in a forecasted valuation of US$18.21 billion by the end of the period. The growth of the medical furniture market is driven by the expanding healthcare infrastructure, rising hospitalization rates, increasing chronic disease burden, and growing demand for advanced, ergonomic, and patient-centric care environments across hospitals, ASCs, and long-term care facilities.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Surgical Anastomosis Devices Market by Product, (Surgical Sutures, Surgical Staplers), Application (Cardiovascular, Gastrointestinal) - Global Forecast to 2023
Anastomosis is a connection made surgically between adjacent blood vessels, parts of the intestine, or other channels of the body. It is achieved by surgically suturing or stapling the two ends of the channel to restore or form a new connection. Vascular anastomosis is performed to connect the blood vessels, for e.g. in cardio vascular surgeries such as by-pass surgery. Similarly, gastrointestinal anastomosis is performed for bowel re-sectioning, for e.g. in Gastrojejunostomy. With increasing ailments of cardiovascular diseases, gastrointestinal surgeries, and organ transplants has resulted in demand for anastomosis devices.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Anastomosis Devices Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries), End Users & Region - Global Forecast to 2027
The global anastomosis devices market in terms of revenue was estimated to be worth $3.0 billion in 2022 and is poised to reach $4.4 billion by 2027, growing at a CAGR of 8.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Surgical Products Market by Product (Surgical Suture & Stapler, Handheld Surgical Devices (Forceps & Spatula, Retractor, Dilator, Auxiliary Device)), Electrosurgical, Arthroscopic Instruments, Application (Plastic, Cardiovascular, Laparoscopy, Surgery), End User - Global Forecast to 2022
The global surgical products market is expected to reach USD 26.57 Billion by 2022 from USD 28.91 Billion in 2017, growing at a CAGR of 7.4% from 2017 to 2022. Rising incidence and prevalence of acute and chronic diseases, ready availability of surgical products, and growing demand for minimally invasive procedures are some of the major driving factors driving the growth of the global surgical products market. However, the high cost of surgical procedure and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
The global minimally invasive surgical instruments market, valued at US$29.9 billion in 2023, stood at US$31.7 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$49.9 billion by the end of the period. The growth of this market is primarily fueled by the rising prevalence of surgical procedures globally, the advantages of minimally invasive surgery over traditional open techniques, and the increasing use of advanced robotics in ambulatory surgical centers.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022
The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Medical Aesthetics Market by Product (Botox, Filler, Peel, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Non-surgical), End User (Hospital, Beauty Clinic, Spa), and Region – Global Forecast to 2031
The global medical aesthetics market, valued at USD 17.30 billion in 2024, stood at USD 19.54 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2031, culminating in a forecasted valuation of USD 40.70 billion by the end of the period. The market is driven by the increasing trend toward minimally invasive and non-surgical treatment options, increased beauty and aesthetic awareness across various demographics, and innovations in injectables, energy-based devices, and combination therapies.
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
